Martínez M A, Real de Asúa D, Torres R, Bernardino J I, Pallardo L F, García-Puig J
Unidad Metabólico-Vascular. Servicio de Medicina Interna.Hospital Universitario La Paz. Madrid. España.
Rev Clin Esp. 2007 Oct;207(9):445-7. doi: 10.1016/s0014-2565(07)73438-0.
Impaired fasting glucose (IFG) is defined by a fasting glucose between 5.6 and 6.9 mmol/l in subjects with no known diabetes. The present study objectives were: a) to analyze the glucose tolerance test (GTT) reproducibility and b) to assess this test's diagnostic classification agreement.
Cross-sectional study in adult patients diagnosed with IFG. Study subjects underwent a 75 g GTT in two occasions.
Fifty-nine patients were studied. The interval between GTT tests was 37 +/- 26 days. Fasting and post-GTT plasma glucose intra-individual variation coefficients were 6.9 and 31.0%, respectively. Diagnostic agreement between the two tests (normal tolerance vs. abnormal tolerance) was measured using the kappa index: 0.62 (95% CI 0.42-0.82). Agreement ranged from 80% (95% CI, 70-90%) to 83% (95% CI, 73-93%) depending on whether the first GGT results were abnormal or normal, respectively.
GTT reproducibility is moderate in patients diagnosed with IFG. Considering this fact, perhaps this test should be repeated before therapeutic decisions are made.
空腹血糖受损(IFG)定义为空腹血糖在5.6至6.9 mmol/l之间且无已知糖尿病的受试者。本研究的目的是:a)分析葡萄糖耐量试验(GTT)的可重复性,以及b)评估该试验的诊断分类一致性。
对诊断为IFG的成年患者进行横断面研究。研究对象分两次进行75 g葡萄糖耐量试验。
共研究了59例患者。葡萄糖耐量试验之间的间隔为37±26天。空腹及葡萄糖耐量试验后血浆葡萄糖的个体内变异系数分别为6.9%和31.0%。使用kappa指数测量两次试验之间的诊断一致性(正常耐量与异常耐量):0.62(95%可信区间0.42 - 0.82)。根据第一次葡萄糖耐量试验结果是否异常,一致性范围分别为80%(95%可信区间,70 - 90%)至83%(95%可信区间,73 - 93%)。
在诊断为IFG的患者中,葡萄糖耐量试验的可重复性为中等。考虑到这一事实,或许在做出治疗决策前应重复该试验。